Comparison of 2 Doses of Corticosteroid Subacromial Injections for the Treatment of Painful Shoulder
Information source: HaEmek Medical Center, Israel
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Tendonitis; Bursitis
Intervention: Betamethasone Sodium Phosphate (Drug); 1 cc - Betamethasone Sodium Phosphate (Drug); 2 cc - Betamethasone Sodium Phosphate (Drug)
Phase: N/A
Status: Withdrawn
Sponsored by: HaEmek Medical Center, Israel
Summary
The use of corticosteroid subacromial injections have been found to be effective for the
treatment of shoulder pain. Higher doses may be better than lower doses for subacromial
corticosteroid injection for rotator cuff tendonitis. The investigators aim this study to
compare 2 doses of corticosteroids.
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: constant score
Eligibility
Minimum age: 35 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- subacromial bursitis
- tendinitis
- Calcific Tendonitis
Exclusion Criteria:
- rotator cuff tear
- osteoarthritis
- pregnancy
- local or systemic infection
- steroid or lidocaine sensitivity
Locations and Contacts
Haemek Medical Center, Afula, Israel
Additional Information
Related publications: van der Heijden GJ, van der Windt DA, Kleijnen J, Koes BW, Bouter LM. Steroid injections for shoulder disorders: a systematic review of randomized clinical trials. Br J Gen Pract. 1996 May;46(406):309-16.
Starting date: June 2009
Last updated: June 21, 2015
|